Strengthening drug safety to increase use of preventive treatment for tuberculosis in Zimbabwe - Clinton Health Access Initiative

CHAI is supporting the Zimbabwe TB national program to not only roll out new anti-TB treatment, but also to support drug safety monitoring to ensure quality of care for patients.

Tuberculosis (TB) is the second leading cause of death from a single infectious agent, next to COVID-19 worldwide.  People who become sick with TB are living with the active form of the disease, howe… [+7646 chars]

full article...